LifePoint Health Inc (NASDAQ:LPNT) – Leerink Swann issued their Q1 2018 EPS estimates for shares of LifePoint Health in a report released on Monday, according to Zacks Investment Research. Leerink Swann analyst A. Gupte forecasts that the company will post earnings per share of $1.08 for the quarter. Leerink Swann has a “Market Perform” rating and a $58.00 price objective on the stock. Leerink Swann also issued estimates for LifePoint Health’s Q2 2018 earnings at $1.10 EPS, Q3 2018 earnings at $1.05 EPS and Q4 2018 earnings at $1.13 EPS.
Several other research firms have also recently commented on LPNT. William Blair reissued an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $50.00 price objective on shares of LifePoint Health in a research note on Friday, February 23rd. SunTrust Banks lowered their price objective on shares of LifePoint Health to $44.00 and set a “hold” rating on the stock in a research note on Monday, February 26th. Morgan Stanley reaffirmed an “equal weight” rating and issued a $46.00 price objective (down previously from $50.00) on shares of LifePoint Health in a research note on Monday, February 26th. Finally, BidaskClub upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $55.00.
LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, February 23rd. The company reported $0.77 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.04). The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a net margin of 1.46% and a return on equity of 6.34%. The company’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.07 earnings per share.
A number of hedge funds have recently made changes to their positions in the stock. American Century Companies Inc. increased its position in LifePoint Health by 16.3% during the fourth quarter. American Century Companies Inc. now owns 4,220,590 shares of the company’s stock worth $210,185,000 after acquiring an additional 590,103 shares during the period. Alliancebernstein L.P. increased its holdings in LifePoint Health by 1.7% in the 4th quarter. Alliancebernstein L.P. now owns 1,762,076 shares of the company’s stock valued at $87,751,000 after buying an additional 28,721 shares during the period. Letko Brosseau & Associates Inc. increased its holdings in LifePoint Health by 3.1% in the 4th quarter. Letko Brosseau & Associates Inc. now owns 1,429,654 shares of the company’s stock valued at $71,197,000 after buying an additional 43,615 shares during the period. Millennium Management LLC increased its holdings in LifePoint Health by 583.3% in the 4th quarter. Millennium Management LLC now owns 947,579 shares of the company’s stock valued at $47,189,000 after buying an additional 808,906 shares during the period. Finally, Boston Partners increased its holdings in LifePoint Health by 50.8% in the 4th quarter. Boston Partners now owns 874,690 shares of the company’s stock valued at $43,559,000 after buying an additional 294,480 shares during the period.
In other news, Chairman William F. Carpenter III purchased 21,368 shares of the company’s stock in a transaction dated Wednesday, February 28th. The shares were bought at an average price of $46.80 per share, with a total value of $1,000,022.40. Following the completion of the transaction, the chairman now directly owns 482,668 shares in the company, valued at approximately $22,588,862.40. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total transaction of $2,183,400.00. Following the transaction, the insider now directly owns 252,673 shares in the company, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. 8.76% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: “LifePoint Health Inc (LPNT) to Post Q1 2018 Earnings of $1.08 Per Share, Leerink Swann Forecasts” was reported by Week Herald and is the property of of Week Herald. If you are reading this story on another publication, it was stolen and republished in violation of international copyright legislation. The correct version of this story can be viewed at https://weekherald.com/2018/03/14/lifepoint-health-inc-forecasted-to-earn-q1-2018-earnings-of-1-08-per-share-lpnt.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.